
51 - 200 funcionários
🧬 Biotecnologia
💊 Farmacêutico
🔥 Investimento no último ano
💰 $30.000.000 Post-IPO Secondary - DBV Technologies em 2025-10
Biotechnology • Pharmaceuticals
A DBV Technologies é uma empresa biofarmacêutica global em estágio clínico que desenvolve imunoterapia epicutânea para tratar alergias alimentares e outras doenças mediadas pelo sistema imunológico. Fundada por pediatras, a empresa está avançando sua tecnologia proprietária de adesivo VIASKIN® através de ensaios clínicos — incluindo estudos de Fase 3 para um adesivo para alergia a amendoim (DBV712) e programas em estágios iniciais para alergia ao leite (DBV135) — com o objetivo de reeducar o sistema imunológico usando a exposição controlada da pele a antígenos.
🕒 Abril 8
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
🧬 Biotecnologia
💊 Farmacêutico
🔥 Investimento no último ano
💰 $30.000.000 Post-IPO Secondary - DBV Technologies em 2025-10
Biotechnology • Pharmaceuticals
A DBV Technologies é uma empresa biofarmacêutica global em estágio clínico que desenvolve imunoterapia epicutânea para tratar alergias alimentares e outras doenças mediadas pelo sistema imunológico. Fundada por pediatras, a empresa está avançando sua tecnologia proprietária de adesivo VIASKIN® através de ensaios clínicos — incluindo estudos de Fase 3 para um adesivo para alergia a amendoim (DBV712) e programas em estágios iniciais para alergia ao leite (DBV135) — com o objetivo de reeducar o sistema imunológico usando a exposição controlada da pele a antígenos.
• Serve as lead for DBV relationship and B2B engagement with assigned accounts • Identify competitive threats and develop response strategies to ensure optimal access for products • Develop and own account-level plans for assigned national or regional payers, inclusive of formulary strategy, coverage policy objectives, and contracting priorities • Establish and maintain executive-level relationships with medical directors, pharmacy directors, and formulary committee decision-makers • Communicate the clinical, economic, and humanistic value of Viaskin® Peanut to payer audiences, translating HEOR data and real-world evidence into decision-relevant insights • Effectively articulate the differentiated profile of EPIT as a novel, non-invasive immunotherapy in a competitive and evolving food allergy treatment landscape • Anticipate and proactively address payer policy questions and potential coverage barriers prior to launch • Partner with patient services and hub operations to ensure reimbursement pathways are operationally aligned with payer coverage decisions • Represent market access in account-level business reviews and brand team planning cycles
• Bachelor’s Degree required; Advanced Degree preferred • A minimum of 10+ years of biotech/pharma of Market Access experience with prior leadership roles in account management and/or sales management • Must complete all required safety and certification training and must maintain an acceptable driving record regarding accidents and incidents • Requires greater than 50% travel • Experience integrating Health Economics and Medical Affairs resources into access planning • Demonstrated ability to collaborate with a diverse matrix of internal stakeholders (e.g., Market Access Account team, field sales, brand marketing, Medical, legal, compliance, Trade, Patient Services, Data & Analytics) to achieve access goals • Ability to identify future policies, practices and trends that will affect payer management and access decision making in the marketplace • Experience leading pull through efforts with sales leadership and field sales teams • Strong Market Access Payer and PBM (Commercial, and Managed Medicaid) understanding • Well-developed negotiation skills • A high level of awareness and understanding of the implications and opportunities of contract strategy • Experience identifying trends and insights and assimilating to development of a broader strategy • Maintain accurate account profiles and customer interactions via CRM.
Candidatar-se🕒 Abril 8
Director of Engagement leading caregiver and patient engagement strategy for Ceresti Health. Driving initiatives for dementia care and maximizing caregiver participation and retention at scale.
🇺🇸 Estados Unidos – Remoto (EUA)
🔥 Investimento no último ano
💰 $11.726.799 Venture Round - Ceresti Health em 2025-08
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 8
Corporate Affairs Director focusing on research communication strategies at Amgen. Developing and implementing strategic communication plans to elevate Amgen's position as a leader in scientific research and innovation.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $180.551 - $244.276 / ano
💰 $28.500.000.000 Post-IPO Debt em 2022-12
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 8
Director of Strategy & Business Development driving organizational growth through government contracts and strategic partnerships in the aerospace ecosystem.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 8
Director of System Implementations overseeing software implementations for healthcare technology company iCareManager. Managing a team and ensuring successful client onboarding experiences.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 7
Director of Acquisition leading end-to-end customer growth at a $500M DTC brand. Overseeing performance for paid, owned, and organic channels at a company investing heavily in media spend.
🗣️🇺🇸🇬🇧 Inglês obrigatório